David Sieber
Plastic and Reconstructive Surgery · San Francisco, CANPI 1760645022
Payments from drug & device makers
What this record shows
The money is spread across several categories — other (53.6%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Surgical Innovation Associates, Inc. at 53.6% of the total. Reporting peaked in 2022 at $107,359 and has fallen 97.3% since, to $2,878 in 2025. Among plastic and reconstructive surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 326 payments — averaging $596.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Surgical Innovation Associates, Inc.$104K
- AbbVie$61K
- Galderma Laboratories, L.p.$14K
- Motiva USA, LLC$7K
- Sientra, Inc.$4K
- Davol Inc.$2K
- plus $3K from 13 others
What the payments were for
- Consulting fees$36,40019%
- Speaking & faculty fees$22,57512%
- Travel & lodging$15,3768%
- Food & beverage$15,7818%
- Gifts$870%
- Other$104,37554%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Surgical Innovation Associates, Inc. | 1 | $104,375 |
| AbbVie(2 entities) | 169 | $60,629 |
| Galderma Laboratories, L.p. | 24 | $14,131 |
| Motiva USA, LLC | 30 | $6,510 |
| Sientra, Inc. | 36 | $4,352 |
| Davol Inc. | 19 | $1,609 |
| Revance Therapeutics, Inc. | 15 | $777 |
| Tepha Inc | 6 | $619 |
| Mentor Worldwide LLC | 5 | $425 |
| TELA Bio, Inc. | 3 | $391 |
| Solta Medical, A Division Of Bausch Health US, LLC | 4 | $362 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $115 |
| Omeros Corporation | 5 | $87 |
| Neuronetics, Inc. | 1 | $62 |
| Bard Peripheral Vascular, Inc. | 2 | $45 |
| Merz North America, Inc. | 2 | $43 |
| BD | 1 | $24 |
| Vertex | 1 | $24 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DuraSorb Monofilament Mesh$104,375
- BOTOX COSMETIC$42,204
- NATRELLE$6,292
- NATRELLE SALINE-FILLED BREAST IMPLANTS$6,148
- Motiva Implant Matrix$5,652
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$3,137
- ALLODERM$1,138
- Phasix Mesh$1,069
- STRATTICE$534
- GalaFLEX$469
- DAXXIFY$342
- MENTOR MemoryGel Resterilizable Gel Sizer$284
- BOTOX$265
- OviTex 2S$259
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$131
How this compares
$194,594 in reported general payments places this provider in the 95th percentile of 349 plastic and reconstructive surgery providers in California.
See all plastic and reconstructive surgery providers in California →
Other plastic and reconstructive surgery in San Francisco
- Corey MaasSan Francisco$286K
- Charles LeeSan Francisco$200K
- Gregory BunckeSan Francisco$105K
- Thomas SatterwhiteSan Francisco$11K
- Mark SuskiThousand Oaks$294K
- Arian MowlaviLaguna Beach$250K
- David KulberLos Angeles$194K
- Matthew NykielUpland$181K
- Subhas GuptaLoma Linda$178K
- Jeffrey HammoudehLos Angeles$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.